Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer

被引:0
|
作者
Narwariya, Abhinav [1 ]
Dhakar, Mhendr [2 ]
Jatav, Jagannath [3 ]
Prajapati, Raju [4 ]
Bayer, Sujata [5 ]
Moosa, Shajiya Sarwar [5 ]
Shaikh, Mohammad Habeebur Raheman [5 ]
Ali, Mohammed Taher [6 ]
Ahmad, Arafat [7 ]
Begum, Yousuf [5 ]
Hiware, Sanket D. [5 ]
机构
[1] Apollo Hosp, Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Radiat Oncol, Raipur, India
[3] Shyam Shah Med Coll & Sanjay Gandhi Mem Hosp, Pathol, Rewa, India
[4] Shyam Shah Med Coll & Sanjay Gandhi Mem Hosp, Radiat Oncol, Rewa, India
[5] Imam Abdulrahman Bin Faisal Univ, Anat, Dammam, Saudi Arabia
[6] Imam Abdulrahman Bin Faisal Univ, Clin Pharmacol, Dammam, Saudi Arabia
[7] Imam Abdulrahman Bin Faisal Univ, Biochem, Dammam, Saudi Arabia
关键词
breast cancer radiotherapy; hypofractionation; lumpectomy; mastectomy; conventional radiotherapy; RADIATION-THERAPY; WOMEN; RISK;
D O I
10.7759/cureus.29147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Breast cancer is the most commonly diagnosed cancer causing death among females worldwide. Radiotherapy after lumpectomy/mastectomy in breast cancer cases is a successful treatment modality taking five weeks to complete. The aim of the present study is to compare the effectiveness of hypo-fractionated radiotherapy in breast cancer patients with conventional radiotherapy with respect to outcome and toxicity.Methods: Sixty patients were randomly divided equally into a conventional group, Group A (dose: 50 Gy in 25 fractions), and a hypo-fractionated short-course radiotherapy group, Group B (dose: 40 Gy in 16 fractions). After thorough clinical and laboratory examination of all patients, the disease status was assessed prior to radiotherapy and three and six months after completion of radiotherapy. The cardiopulmonary function was assessed using echocardiography and pulmonary function tests prior to the procedure. The assessment of the development of toxicity (dysphagia, skin, lung, and lymphedema) was done during every clinical visit.Results: The mean age of patients was 53.28 +/- 9.73 years in Group A, and 55.67 +/- 10.41 years in Group B (p=0.82). The right breast was involved in 13 (43.4%) patients in Group A and 14 (46.6%) in Group B, and the left breast was involved n 17 (56.6%) patients in Group A and 16 (53.4%) in Group B (p=0.81). Most of the patients were post-menopausal; 24 (80%) in Group A and 25 (83.4%) in Group B (p=0.91). Eleven (36.6%) patients were of stage T2N1M0 in both groups. However, no statistical difference was observed between the groups in the TNM (tumor, node, and metastasis) staging using the AJCC (American Joint Committee on Cancer) criteria (p=0.26). On comparing the responses in Group A and Group B, no significant difference was observed in either of the groups from immediate post-treatment to the 12-month follow-up period (p=0.53 and p=0.64, respectively).Conclusion: Hypo-fractionated radiotherapy is as effective as conventional radiotherapy and can be used as an alternative method for treatment following breast cancer surgery.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Palliative Hypo-fractionated Radiotherapy in Locally Advanced Head and Neck Cancer with Fixed Neck Nodes
    Paliwal, Rajan
    Kumar-Patidar, Arvind
    Walke, Rahul
    Hirapara, Pushpendra
    Jain, Sandeep
    Raj-Bardia, Megh
    IRANIAN JOURNAL OF CANCER PREVENTION, 2012, 5 (04) : 178 - 182
  • [42] Could VMAT Provide Advantages in the Treatment of Hypo-fractionated Stereotactic Lung Radiotherapy?
    Webster, G. J.
    Rowbottom, C. G.
    Lee, L. W.
    Faivre-Finn, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S684 - S684
  • [43] Clinical Outcomes of Hypo-fractionated Radiotherapy and Intercalated Brachytherapy in Cervical Carcinoma: A Prospective Clinical Study
    Ananth, R.
    Pandjatcharam, J.
    Parthasarathy, V.
    Rajkumar, N.
    CLINICAL ONCOLOGY, 2024, 36 (09) : E365 - E366
  • [44] Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
    Kim, Dong-Yun
    Park, Eonju
    Heo, Chan Yeong
    Jin, Ung Sik
    Kim, Eun Kyu
    Han, Wonshik
    Shin, Kyung Hwan
    Kim, In Ah
    BREAST, 2021, 55 : 37 - 44
  • [45] Norm-and hypo-fractionated radiotherapy is capable of activating human dendritic cells
    Kulzer, Lorenz
    Rubner, Yvonne
    Deloch, Lisa
    Allgaeuer, Andrea
    Frey, Benjamin
    Fietkau, Rainer
    Doerrie, Jan
    Schaft, Niels
    Gaipl, Udo S.
    JOURNAL OF IMMUNOTOXICOLOGY, 2014, 11 (04) : 328 - 336
  • [46] Pareto Navigation Guided Automated Planning for Extreme Hypo-fractionated Prostate Radiotherapy
    Berenato, S.
    Abbott, N.
    Woodley, O.
    Chu, M.
    Palaniappan, N.
    Millin, A.
    Wheeler, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S432 - S433
  • [47] Enhancing Hypo-Fractionated Prostate Cancer Radiotherapy in Nigeria: A Knowledge-Based Treatment Planning Approach
    Adeneye, S. O.
    Joseph, A.
    Miracle, M. C.
    Ibitoye, A.
    Lehmann, J.
    Avery, S. M.
    Mkhize, T.
    Kisukari, J. Dachi
    Mallum, A.
    Alabi, A.
    Oderinde, O.
    Taiwo, M. D.
    Dinyo, A.
    Olatunji, E.
    Graef, K.
    Wijesooriya, K.
    Huq, M. S.
    Swanson, W. J.
    Li, H.
    Patel, S.
    Ajose, A.
    Ngoma, T.
    Ngwa, W. F.
    Weygand, J.
    MEDICAL PHYSICS, 2024, 51 (10) : 7815 - 7816
  • [48] IS FEASIBLE THE HYPO-FRACTIONATED BOOST IN THE RADIATION TREATMENT OF BREAST CANCER?
    Sanz, X.
    Rodriguez, N.
    Arnalot, P. Foro
    Lacruz Bassols, M.
    Reig, A.
    Quera Jordana, J.
    Lozano, J.
    Fernandez-Velilla, E.
    Membrive Conejo, I.
    Algara Lopez, M. I.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S239 - S239
  • [49] Hypo-fractionated biological optimized dose-painting radiotherapy for high-risk prostate cancer
    Syndikus, I.
    Uzan, J.
    Onjukka, E.
    Nahum, A.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S663 - S664
  • [50] Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases
    Yang, Siran
    Ma, Yuchao
    Xu, Yingjie
    Liu, Qingfeng
    Zhang, Ye
    Huang, Xiaodong
    Chen, Xuesong
    Wang, Kai
    Zhao, Ruizhi
    Xiao, Jianping
    Zhang, Hongmei
    RADIATION ONCOLOGY, 2023, 18 (01)